Clinical and EEG investigations with CI-579 and CI-600 (quantitative pharmacoelectroencephalography and "sleep prints").
D000328:Adult; D000928:Antidepressive Agents / Q000494:pharmacology; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects*; D002986:Clinical Trials as Topic; D003201:Computers; D003344:Cortical Synchronization; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy*; D004123:Dimethylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011437:Propylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012890:Sleep / Q000187:drug effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013610:Tachycardia / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000494:pharmacology
D000928:Antidepressive Agents; D001570:Benzodiazepinones; D004123:Dimethylamines; D011437:Propylamines; D014149:Tranquilizing Agents